(An active ingredient is what makes a drug work.) Keytruda is a biologic medication. A biologic is made from parts of living organisms. It’s available only as a brand-name drug. Keytruda isn’t ...

The company also has a solid dividend record. Its payouts have increased by 71% in the past decade, and it currently offers a ...

Merck CEO Robert Davis joins 'Squawk Box' to discuss the company's quarterly earnings results, which topped expectations as the company saw strong sales from its top-selling cancer drug Keytruda, ...

Furthermore, Keytruda will lose patent exclusivity in the U.S. in 2028 and then face generic competition ... Its most-recent, brand-new approval of Winrevair, a medicine for pulmonary arterial ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

Welcome to the Merck & Company Q3 sales and earnings conference call. [Operator instructions] This call is being recorded.

Merck's most important product is Keytruda, a cancer drug that has won approval to treat ... Not everything will make it to market, but I expect many brand-new approvals and label expansions ...

Both Opdivo and Keytruda are still in the foothills ... The glucagon-like peptide-1 (GLP-1) analogue drug is already licensed to treat diabetes under the brand name Victoza, but this year gained ...

Padcev (enfortumab vedotin-ejfv) is a brand-name infusion prescribed for ... A boxed warning is the most serious warning from the Food and Drug Administration (FDA). For details, see the ...

Cabozantinib is Exelixis’ lead drug marketed under the brand name Cabometyx for the treatment of RCC. Keytruda is approved for several oncology indications. The pipeline progress has also been ...